Is prostate cancer stage T2 considered early or mid-stage?

Written by Yan Chun
Oncology
Updated on January 25, 2025
00:00
00:00

Prostate cancer stage T2 is considered early or intermediate, but it is also necessary to understand the patient's N and M status. If the patient is at stage T2, and both N and M are at stage 0, then it is considered early-stage prostate cancer. If the primary lesion is at stage T2, but N1 is present and there is no metastasis (M), then the patient is considered to have intermediate-stage prostate cancer. If the primary lesion is at stage T2, but there is metastasis in N and M, then the patient's clinical stage is considered advanced. The clinical staging of prostate cancer not only requires understanding of the primary lesion T, but also involves the regional lymph nodes N and distant metastasis M.

Other Voices

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
40sec home-news-image

androgen deprivation therapy for prostate cancer

Androgen deprivation therapy for prostate cancer includes surgical castration, which can quickly and continuously reduce levels to very low levels. The second is medical castration, which involves the use of analogs of luteinizing hormone-releasing hormone. Currently available products include leuprolide, goserelin, and triptorelin. Third, estrogen therapy, with diethylstilbestrol being the most common estrogen treatment. Surgical castration, medical castration, or estrogen therapy offer similar progression-free survival rates in patients with tumor-related outcomes.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
31sec home-news-image

What are the symptoms of bone metastasis from prostate cancer?

Bone metastasis is the most common site of metastasis for prostate cancer, with the lumbar vertebrae being the most common site. Eighty percent of bone metastases in prostate cancer are osteoblastic changes. The main symptoms caused by bone metastasis are bone pain, pathological fractures, anemia, and if the spinal cord is compressed, it can cause paralysis of the lower limbs, weakness, incontinence, and other symptoms.

doctor image
home-news-image
Written by Liu Liang
Oncology
48sec home-news-image

How is prostate cancer formed?

The causes of prostate cancer are not yet very clear. According to relevant data analysis, the occurrence of prostate cancer may be related to prostate gonorrhea, infections with viruses or chlamydia, as well as the intensity of sexual activity and the impact of hormones. On the other hand, a high-fat diet and some occupational factors are also somewhat related to the disease. Therefore, the formation of prostate cancer is the result of multifactorial influences including environmental and genetic factors, personal lifestyle habits, and dietary habits, all of which are significantly interconnected.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
36sec home-news-image

What are the causes of prostate cancer?

At present, there are many factors that cause prostate cancer, but its exact etiology remains unclear. It may be related to genetic factors, gene changes, prostate gonococcal and chlamydial infections, intensity of sexual activity, and the influence of hormones. Additionally, dietary habits, long-term consumption of high-fat foods, and occupational hazards, such as excessive exposure to chromium, may also be related to the development of the disease.

doctor image
home-news-image
Written by Liu Liang
Oncology
1min home-news-image

How long can one survive with prostate cancer?

The life expectancy of prostate cancer patients depends on the clinical stage at diagnosis, as well as the patient's sensitivity to various treatments such as endocrine therapy, chemotherapy, and radiotherapy. Patients diagnosed at earlier stages who are more responsive to treatment generally have better treatment outcomes and, consequently, a longer survival period compared to those who are diagnosed at later stages and have poor responses to treatment. Overall, prostate cancer patients tend to have a relatively long disease course, and the prognosis is generally good. Even patients with advanced prostate cancer exhibiting extensive bone metastasis can survive several years due to the effectiveness of endocrine treatments. The disease itself progresses slowly, so the prognosis for this type of cancer is comparatively favorable.